Exercise Intervention in Patients With Nontuberculous Mycobacterial Pulmonary Disease
Improving Prognosis and Evaluating Patient Experience Through Exercise Intervention in Patients With Nontuberculous Mycobacterial Pulmonary Disease
1 other identifier
interventional
23
1 country
1
Brief Summary
The study goal is to develop exercise intervention methods to improve the prognosis and quality of life of patients with non-tuberculous mycobacterial lung disease and to confirm the effectiveness of exercise intervention. This prospective study is scheduled to be conducted as a pre-post single-arm feasibility trial, targeting a total of 50 subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2023
CompletedFirst Submitted
Initial submission to the registry
November 22, 2023
CompletedFirst Posted
Study publicly available on registry
December 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2024
CompletedJuly 8, 2024
December 1, 2023
6 months
November 22, 2023
July 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
VO2max
The patient wears a mask that transmits inhalation and exhalation to a gas analyzer on the treadmill and a heart rate monitor that measures heart rate. The treadmill gradually increases the incline and increases the speed. When the patient runs as far as they can run and raises their hand to show the measurer, the patient's VO2max is measured by measuring the maximum amount of oxygen that can be taken in and heart rate.
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
Secondary Outcomes (16)
The 6-Minute Walk Test
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
30-Second Sit-to-Stand
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
Short Physical Performance Battery
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
Muscular strength (Handgrip strength in kilograms)
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
COPD Assessment Test
within the first 1 week (plus or minus 1 week) after the end of exercise intervention
- +11 more secondary outcomes
Study Arms (1)
Exercise intervention
EXPERIMENTALInterventions
The exercise intervention method is a circuit training method that combines strength training and aerobic exercise forms and consists of a total of 12 movements. Performing movements 1 to 12 in order is 1 set. After completing the set, when the heart rate returns to the plateau (less than 59% of maximum heart rate), proceed to the next set, for a total of 3 sets.
Eligibility Criteria
You may qualify if:
- Adults aged 19 to 80 years diagnosed with non-tuberculous mycobacterial lung disease according to the ATS/IDSA guideline, Patients with respiratory symptoms (cough, phlegm, difficulty breathing, etc.) at the time of selection, Patients who understand the purpose of the clinical study and voluntarily agree to participate in this clinical study
You may not qualify if:
- Patients diagnosed with cardiovascular disease (Angina, HFrEF, arrhythmia, history of heart valve surgery, etc.), Patients who have had massive hemoptysis within the last 3 months, Patients who have difficulty moving freely due to musculoskeletal problems (osteoarthritis, intervertebral disc herniation, spinal stenosis, etc.), Patients who cannot read the consent form (e.g. illiterate, foreigner, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2023
First Posted
December 21, 2023
Study Start
July 10, 2023
Primary Completion
January 10, 2024
Study Completion
February 20, 2024
Last Updated
July 8, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share